Information Provided By:
Fly News Breaks for February 26, 2020
Feb 26, 2020 | 08:16 EDT
SunTrust analyst Sandy Draper raised his price target on Medpace to $100 after its Q4 earnings beat that reflected the quarter's strong net bookings momentum in spite of the higher cancellations. The analyst also notes that the below-consensus FY20 guidance appears to have some "conservatism", but he still keeps his Hold rating, citing his view of limited opportunity for earnings acceleration and further multiple expansion.
News For MEDP From the Last 2 Days
There are no results for your query MEDP